Connect Biopharma Holdings Ltd (CNTB)

Sep 22, 2025

Eosinophilic Asthma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Lanier Biotherapeutics, Bio-Thera Solutions, Kinaset Therapeutics, CSPC ZhongQi Pharma - Barchart.com

Sep 22, 2025

Sep 22, 2025

Eosinophilic Asthma Pipeline 2025: Therapies, MOA Insights, - openPR.com

Sep 22, 2025

Sep 20, 2025

FY2025 EPS Estimate for Connect Biopharma Lowered by Analyst - MarketBeat

Sep 20, 2025

Sep 18, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Sees Large Drop in Short Interest - MarketBeat

Sep 18, 2025

Sep 09, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Short Interest Up 204.8% in August - MarketBeat

Sep 09, 2025

Sep 08, 2025

Asthma Market to Show Paltry Growth at a CAGR of 1.95% During the Forecast Period (2025-2034) | DelveInsight - Yahoo Finance

Sep 08, 2025

Sep 06, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Sees Large Increase in Short Interest - Defense World

Sep 06, 2025

Sep 04, 2025

Connect Biopharma Announces Poster Presentations of Rademikibart at the European Respiratory Society Congress 2025 - Quiver Quantitative

Sep 04, 2025

Sep 04, 2025

New Asthma Treatment Data: Connect Biopharma's Rademikibart Shows Impact on FEV1 in Type 2 Asthma Trial - Stock Titan

Sep 04, 2025

Sep 03, 2025

Connect Biopharma completes termination of its American depositary receipt program and directly lists its ordinary shares on Nasdaq - MarketScreener

Sep 03, 2025

Sep 03, 2025

Connect Biopharma Ends ADR Program, Moves to Direct Nasdaq Listing; Shares Up Premarket - MarketScreener

Sep 03, 2025

Sep 03, 2025

Connect Biopharma Completes Termination of its American - GlobeNewswire

Sep 03, 2025

Sep 03, 2025

Biotech Connect Biopharma Completes Strategic Shift to Direct Nasdaq Listing for U.S. Growth - Stock Titan

Sep 03, 2025

Sep 03, 2025

Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq - Yahoo Finance

Sep 03, 2025

Sep 02, 2025

COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com

Sep 02, 2025

Sep 02, 2025

3 Penny Stocks To Watch With Market Caps Over $100M - simplywall.st

Sep 02, 2025

Aug 29, 2025

Connect Biopharma (CNTB) Expected to Announce Quarterly Earnings on Friday - Defense World

Aug 29, 2025

Aug 27, 2025

Connect Biopharma Holdings Limited to Participate in Upcoming Healthcare Conferences - Quiver Quantitative

Aug 27, 2025

Aug 27, 2025

Clinical-Stage Biotech Connect Biopharma Announces Key September Investor Conference Appearances - Stock Titan

Aug 27, 2025

Aug 26, 2025

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate - Yahoo Finance

Aug 26, 2025

Aug 23, 2025

Connect Biopharma (NASDAQ:CNTB) Upgraded to Hold at Wall Street Zen - Defense World

Aug 23, 2025

Aug 20, 2025

Connect Biopharma Advances Clinical Trials and Nasdaq Listing - AInvest

Aug 20, 2025

Aug 18, 2025

Connect Biopharma Posts Q2 Revenue Drop - AOL.com

Aug 18, 2025

Aug 18, 2025

Q3 Earnings Estimate for CNTB Issued By Leerink Partnrs - Defense World

Aug 18, 2025

Aug 16, 2025

HC Wainwright Cuts Earnings Estimates for Connect Biopharma - Defense World

Aug 16, 2025

Aug 15, 2025

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - Yahoo Finance

Aug 15, 2025

Aug 14, 2025

Connect Biopharma Reports Q2 Revenue Drop of 99.2% to $48,000, R&D Spending Increases 65.6% to $8.8mln - AInvest

Aug 14, 2025

Aug 14, 2025

Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide - Yahoo Finance

Aug 14, 2025

Aug 13, 2025

Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView

Aug 13, 2025

Aug 13, 2025

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 13, 2025

Aug 08, 2025

Asthma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight - openPR.com

Aug 08, 2025

Aug 06, 2025

Connect Biopharma Holdings Limited shares rise 5.63% after-hours following Jazz Pharmaceuticals' FDA approval of Modeyso. - AInvest

Aug 06, 2025

Aug 01, 2025

Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN

Aug 01, 2025

Jul 30, 2025

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jul 30, 2025

Jul 27, 2025

Research Analysts Set Expectations for CNTB Q2 Earnings - MarketBeat

Jul 27, 2025

Jul 25, 2025

Connect Biopharma (NASDAQ:CNTB) Upgraded at Northland Capmk - Defense World

Jul 25, 2025

Jul 25, 2025

Q2 Earnings Estimate for CNTB Issued By Northland Capmk - Defense World

Jul 25, 2025

Jul 23, 2025

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) Market Cap Rose US$51m Last Week; Private Equity Firms Who Hold 42% Profited and so Did Insiders - 富途牛牛

Jul 23, 2025

Jul 22, 2025

Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com Australia

Jul 22, 2025

Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors - Investing.com Australia

Jul 22, 2025

Jul 22, 2025

Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Northland starts Connect Biopharma at Outperform on chance to define new class - TipRanks

Jul 22, 2025

Jul 21, 2025

Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com

Jul 21, 2025

Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com India

Jul 21, 2025